CBT4CBT-Buprenorphine for Opioid Use Disorder

(OUD Trial)

This trial explores how social interactions affect treatment outcomes for individuals with opioid use disorder (OUD). It combines a digital therapy program, CBT4CBT-Buprenorphine, with buprenorphine, a medication that helps manage OUD, to assess their combined effectiveness. The trial seeks participants who have used buprenorphine for no more than four weeks and have a supportive significant other willing to join the study. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could enhance treatment strategies for OUD.

The trial requires that you continue taking buprenorphine as prescribed by your provider. The protocol does not specify if you need to stop other medications, so it's best to discuss this with the study team.

Research has shown that CBT4CBT, a computer-based therapy, combined with buprenorphine is generally safe for people with opioid use disorder (OUD). Studies found that patients who tried this treatment reported high satisfaction, with scores averaging 4.9 out of 5, indicating a positive experience for most participants.

The treatment effectively reduced drug use and supported recovery. It also demonstrated good retention rates, meaning participants could maintain the treatment over time. This is important because it shows the treatment is not only helpful but also easy to continue.

Researchers are excited about CBT4CBT-Buprenorphine for opioid use disorder because it combines cognitive behavioral therapy (CBT) with buprenorphine treatment in a digital format. Unlike traditional treatments that typically involve medication or in-person therapy sessions, this approach offers an innovative way to deliver effective therapy through an online platform. This digital delivery can make treatment more accessible and convenient for patients, potentially improving adherence and outcomes. Additionally, integrating CBT with buprenorphine may enhance the overall effectiveness of the treatment by addressing both the psychological and physical aspects of opioid addiction simultaneously.

Research has shown that combining Cognitive Behavioral Therapy (CBT) with buprenorphine can be very effective for people with opioid use disorder (OUD). For those primarily using prescription opioids, CBT helps maintain abstinence. This treatment increases the likelihood of avoiding opioids. Studies suggest that adding structured counseling to buprenorphine treatment enhances its effectiveness. Early results from trials with CBT4CBT-Buprenorphine, the treatment under study in this trial, have shown promising outcomes, with fewer drug-positive tests. Overall, this combined approach appears to be a strong option for improving recovery from opioid addiction.²⁶⁷⁸⁹